Page last updated: 2024-08-25

bufrolin and lodoxamide ethyl

bufrolin has been researched along with lodoxamide ethyl in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caltabiano, G; Charlton, SJ; Fawcett, L; Hudson, BD; Jenkins, L; Kent, TC; MacKenzie, AE; Markwick, R; McCallum, JE; Milligan, G; Nicklin, SA	1

Other Studies

1 other study(ies) available for bufrolin and lodoxamide ethyl

Article	Year
The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35. Molecular pharmacology, 2014, Volume: 85, Issue:1 Topics: Animals; Anti-Allergic Agents; Cell Line; Computer Simulation; Cricetinae; Cricetulus; Humans; Mast Cells; Molecular Docking Simulation; Mutation; Oxamic Acid; Phenanthrolines; Polymorphism, Single Nucleotide; Rats; Receptors, G-Protein-Coupled	2014

Article

Year

The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35.

Molecular pharmacology, 2014, Volume: 85, Issue:1

Topics: Animals; Anti-Allergic Agents; Cell Line; Computer Simulation; Cricetinae; Cricetulus; Humans; Mast Cells; Molecular Docking Simulation; Mutation; Oxamic Acid; Phenanthrolines; Polymorphism, Single Nucleotide; Rats; Receptors, G-Protein-Coupled

2014